Published in Biol Psychiatry on February 01, 2004
Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry (2006) 2.93
Packages of care for depression in low- and middle-income countries. PLoS Med (2009) 2.50
Autobiographical memory and electroconvulsive therapy: do not throw out the baby. J ECT (2014) 1.57
Antidepressant and neurocognitive effects of isoflurane anesthesia versus electroconvulsive therapy in refractory depression. PLoS One (2013) 1.48
Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention. J ECT (2008) 1.47
A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry (2009) 1.24
Current issues in the classification of psychotic major depression. Schizophr Bull (2007) 1.22
Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT. J Psychiatr Pract (2009) 1.06
Treatment-resistant depression: recent developments and future directions. Depress Anxiety (2008) 1.05
Electroconvulsive therapy and its different indications. Dialogues Clin Neurosci (2008) 0.99
Electroconvulsive therapy: Part II: a biopsychosocial perspective. J Psychiatr Pract (2009) 0.93
A functional MRI marker may predict the outcome of electroconvulsive therapy in severe and treatment-resistant depression. Mol Psychiatry (2014) 0.92
The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Front Hum Neurosci (2013) 0.92
Vagus nerve stimulation for epilepsy and depression. Neurotherapeutics (2008) 0.92
Challenges in the treatment of major depressive disorder with psychotic features. Schizophr Bull (2013) 0.92
Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT. J Affect Disord (2012) 0.91
Promoting recovery of sexual functioning after radical prostatectomy with group-based stress management: the role of interpersonal sensitivity. J Psychosom Res (2008) 0.90
Vagus Nerve Stimulation (VNS) and Treatment of Depression: To the Brainstem and Beyond. Psychiatry (Edgmont) (2006) 0.84
A randomized controlled trial of brief and ultrabrief pulse right unilateral electroconvulsive therapy. Int J Neuropsychopharmacol (2014) 0.81
Vagal Nerve Stimulation for Treatment-Resistant Depression. Neurotherapeutics (2017) 0.80
Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry (London) (2014) 0.78
Predictors of the short-term responder rate of Electroconvulsive therapy in depressive disorders--a population based study. BMC Psychiatry (2012) 0.78
Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review. Clin Psychopharmacol Neurosci (2013) 0.76
Relapse prevention after index electroconvulsive therapy in treatment-resistant depression. Ann Clin Psychiatry (2014) 0.76
Low efficacy electroconvulsive therapy in community settings. Biol Psychiatry (2004) 0.75
Economic evaluation of resistant major depressive disorder treatment in Iranian population: a comparison between repetitive Transcranial Magnetic Stimulation with electroconvulsive. Med J Islam Repub Iran (2016) 0.75
Rational electroconvulsive therapy electrode placement. Psychiatry (Edgmont) (2005) 0.75
A naturalistic study of high-dose unilateral ECT among severely depressed inpatients: how does it work in the clinical practice? BMC Psychiatry (2016) 0.75
Effects of Hesel-coil deep transcranial magnetic stimulation for depression - a systematic review. Nord J Psychiatry (2016) 0.75
Adjunctive psychotropic medications during electroconvulsive therapy in the treatment of depression, mania, and schizophrenia. J ECT (2010) 0.75
Electro-convulsive Therapy: A Few Lingering Thoughts/Doubts! Indian J Psychol Med (2011) 0.75
Electroconvulsive Therapy in the Treatment of Mood Disorders: One-Year Follow-up. Noro Psikiyatr Ars (2016) 0.75
Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 13.63
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41
Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med (2005) 8.52
National trends in the outpatient treatment of depression. JAMA (2002) 7.09
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials (2004) 6.64
Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 6.03
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry (2007) 5.59
The most expensive medical conditions in America. Health Aff (Millwood) (2002) 5.50
National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry (2007) 5.49
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am (2003) 5.05
National patterns in antidepressant medication treatment. Arch Gen Psychiatry (2009) 4.82
Sudden death and use of stimulant medications in youths. Am J Psychiatry (2009) 4.33
Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry (2004) 3.84
Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology (2006) 3.80
Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Arch Gen Psychiatry (2002) 3.71
Changing profiles of service sectors used for mental health care in the United States. Am J Psychiatry (2006) 3.64
Trends in mental health care among children and adolescents. N Engl J Med (2015) 3.54
Mental health of college students and their non-college-attending peers: results from the National Epidemiologic Study on Alcohol and Related Conditions. Arch Gen Psychiatry (2008) 3.52
Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry (2006) 3.50
Trends in care by nonphysician clinicians in the United States. N Engl J Med (2003) 3.24
Retractions in the research literature: misconduct or mistakes? Med J Aust (2006) 3.17
Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry (2008) 3.15
Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry (2010) 3.14
Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry (2010) 3.14
National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry (2003) 3.07
A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry (2004) 3.00
Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry (2008) 2.86
Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care (2011) 2.81
Interventions to improve medication adherence in schizophrenia. Am J Psychiatry (2002) 2.78
Parietal cortex and representation of the mental Self. Proc Natl Acad Sci U S A (2004) 2.73
National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry (2012) 2.52
Declining use of electroconvulsive therapy in United States general hospitals. Biol Psychiatry (2012) 2.50
Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry (2003) 2.40
Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood) (2003) 2.37
Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics (2008) 2.32
Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology (2008) 2.31
Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Aff (Millwood) (2009) 2.29
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry (2005) 2.24
National trends in outpatient psychotherapy. Am J Psychiatry (2010) 2.24
National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry (2002) 2.22
Comparison of objective and patient-reported hot flash measures in men with prostate cancer. J Support Oncol (2009) 2.20
Response inhibition predicts poor antidepressant treatment response in very old depressed patients. Am J Geriatr Psychiatry (2007) 2.18
Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J Neurosci (2007) 2.12
Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol (2003) 2.08
Major depression in community-dwelling middle-aged and older adults: prevalence and 2- and 4-year follow-up symptoms. Psychol Med (2004) 2.02
National trends in psychotherapy by office-based psychiatrists. Arch Gen Psychiatry (2008) 1.99
National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry (2010) 1.99
Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry (2013) 1.95
Adequacy of antidepressant treatment after discharge and the occurrence of suicidal acts in major depression: a prospective study. Am J Psychiatry (2002) 1.95
Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study. Arch Gen Psychiatry (2006) 1.93
National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry (2010) 1.93
National trends in ethnic disparities in mental health care. Med Care (2007) 1.91
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry (2005) 1.90
Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report. J Clin Psychiatry (2006) 1.90
Training and consultation to promote implementation of an empirically supported treatment: a randomized trial. Psychiatr Serv (2012) 1.87
Parental depression, child mental health problems, and health care utilization. Med Care (2003) 1.86
National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. J Am Acad Child Adolesc Psychiatry (2010) 1.84
National trends in hospitalization of youth with intentional self-inflicted injuries. Am J Psychiatry (2005) 1.80
Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2011) 1.80
National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders. Am J Psychiatry (2011) 1.79
A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Comput (2005) 1.78
Decline in placebo-controlled trial results suggests new directions for comparative effectiveness research. Health Aff (Millwood) (2013) 1.76
Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry (2007) 1.76
Medication use in US youth with mental disorders. JAMA Pediatr (2013) 1.75
Hyperlipidemia following treatment with antipsychotic medications. Am J Psychiatry (2006) 1.74
Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Arch Gen Psychiatry (2008) 1.73
Screening for bipolar disorder in a primary care practice. JAMA (2005) 1.72
The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology (2006) 1.71
National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication. J Clin Psychiatry (2008) 1.69
Depression in US Hispanics: diagnostic and management considerations in family practice. J Am Board Fam Pract (2005) 1.69
Service implications of providing intensive monitoring during high-risk periods for suicide among VA patients with depression. Psychiatr Serv (2009) 1.68
Continuity of care after inpatient discharge of patients with schizophrenia in the Medicaid program: a retrospective longitudinal cohort analysis. J Clin Psychiatry (2010) 1.67
Adding or switching antipsychotic medications in treatment-refractory schizophrenia. Psychiatr Serv (2007) 1.67
Vascular depression: A distinct diagnostic subtype? Biol Psychiatry (2006) 1.66
Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff (Millwood) (2011) 1.64
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT (2013) 1.62
Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects. Neuroimage (2003) 1.62
Absence of histological lesions in primate models of ECT and magnetic seizure therapy. Am J Psychiatry (2004) 1.60
Depression in African Americans: breaking barriers to detection and treatment. J Fam Pract (2006) 1.60
National trends in the use of outpatient psychotherapy. Am J Psychiatry (2002) 1.59
Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder. Am J Psychiatry (2004) 1.59
Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry (2005) 1.57
Psychiatric opinion and antipsychotic selection in the management of schizophrenia. Psychiatr Serv (2008) 1.56
Evidence-based practice for acute low back pain in primary care: patient outcomes and cost of care. Pain (2006) 1.52
Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol (2002) 1.51
Delays in initial treatment contact after first onset of a mental disorder. Health Serv Res (2004) 1.50
Antipsychotic dosage at hospital discharge and outcomes among persons with schizophrenia. Psychiatr Serv (2003) 1.50
Growth and decentralization of the medical literature: implications for evidence-based medicine. J Med Libr Assoc (2005) 1.50
Length of stay of pediatric mental health emergency department visits in the United States. J Am Acad Child Adolesc Psychiatry (2011) 1.49
Understanding mental health treatment in persons without mental diagnoses: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry (2007) 1.49
Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry (2002) 1.48
A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry (2005) 1.48
Tracking publication outcomes of National Institutes of Health grants. Am J Med (2005) 1.48
Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts. J Affect Disord (2008) 1.48